The Utility of Long Acting Medications During
COVID-19 and Beyond
Please join us and Janssen Pharmaceutical Companies of Johnson & Johnson for a public webinar about the efficacy of long acting medications (LAMs). This webinar will highlight the utility of LAMs with leading experts in the field including representatives from: Substance Abuse and Mental Health Services Administration (SAMHSA), National Council for Behavioral Health (NCBH), National Alliance on Mental Illness (NAMI), and CAC Corporate Partners’ physician and researcher representatives. Attendees will learn how LAMs can serve as an optimal treatment modality for a variety of disorders during and beyond the COVID-19 pandemic. Click here for event flyer and here for the agenda.
August 10, 2020
10:00 am to 12:00 pm PT
We are excited to announce the following panelists. For more information on the panelists, click on their names for their bios.
Director of Center for Mental
Substance Abuse and Mental Health Services Administration
Vice President, Practice Improvement & Medical Director
National Council for Behavioral Health
Scientific Vice President
Janssen Pharmaceuticals Research & Development, LLC
Thank you to the following Corporate Partner for making this event possible!